Norditropin Nordiflex (Somatropin)

Somatropin, the active ingredient in Norditropin Nordiflex, is a growth hormone presented as a recombinant human growth factor for subcutaneous use. It is prescribed for children and adults with growth hormone deficiency and related disorders to support normal growth and metabolic function.

GNH USA supplies Norditropin Nordiflex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for biologic products. Our global network ensures timely delivery to diverse healthcare settings.

Norditropin Nordiflex (somatropin) is used to treat conditions related to growth hormone deficiency and associated growth disorders. - Growth hormone deficiency: promotes linear growth and improves metabolic parameters in children and adults with confirmed deficiency. - Turner syndrome: enhances stature and supports normal development in affected females. - Prader‑Willi syndrome: improves growth velocity and body composition. - Chronic renal insufficiency: aids growth in pediatric patients with renal disease. - Idiopathic short stature: increases height potential in children with unexplained short stature.

Common Side Effects: - Injection site reactions: redness, swelling, or pain at the administration site. - Headache: mild to moderate intensity, often transient. - Joint pain: discomfort in large joints such as knees or elbows. - Edema: peripheral swelling, especially in the ankles.

Serious or Rare Side Effects: - Intracranial hypertension: signs include severe headache, visual disturbances, or nausea. - Slipped epiphysis: risk of growth plate fracture in rapidly growing children. - Severe allergic reaction: rash, urticaria, or anaphylaxis requiring immediate medical attention.

Before initiating therapy, evaluate patient history and monitor regularly. - Screen for malignancy: assess personal or family cancer history before starting treatment. - Monitor glucose: watch for hyperglycemia, especially in diabetic patients. - Assess for intracranial hypertension: observe for persistent headaches or visual changes. - Avoid in active malignancy: contraindicated in patients with current cancer. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin may interact with several medications; monitoring is advised. Major Interactions (Avoid): - Glucocorticoids: may reduce somatropin efficacy. - Insulin: may increase insulin requirements and affect glycemic control. - Oral estrogen: can antagonize growth hormone action. Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: dose adjustments may be needed. - Diuretics: monitor for fluid retention and electrolyte imbalance. - SSRIs (selective serotonin reuptake inhibitors): observe for mood changes or altered response.